Genetic Technologies Ltd (GENE) SEC Filing 20-F Annual report for the fiscal year ending Monday, June 30, 2014

Genetic Technologies Ltd

CIK: 1166272 Ticker: GENE

View differences made from one year to another to evaluate Genetic Technologies Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Genetic Technologies Ltd.


Assess how Genetic Technologies Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Genetic Technologies Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: GENE
CIK: 1166272
Form Type: 20-F Annual Report
Accession Number: 0001104659-14-074541
Submitted to the SEC: Wed Oct 29 2014 6:00:55 AM EST
Accepted by the SEC: Wed Oct 29 2014
Period: Monday, June 30, 2014
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: